Zai Lab Limited (Nasdaq: Zlab) has just published its annual results, and analysts update their estimates

Investors in Zai Lab Limited (Nasdaq: Zlab) had a good week because their shares rose by 2.5% of USD 34.64 after the publication of his annual results. The turnover achieved $ 399 million in accordance with the forecasts, although the company reported a legal loss per share of USD 2.60, which was somewhat smaller than the expected analysts. The analysts usually update their forecasts in every winning report, and according to their estimates, we can assess whether their view of the company has changed or whether new concerns are known. That is why we have collected the latest forecasts after the preservation to see which estimates are kept for next year.

Take a look at our latest analysis for Zai Lab

Taking into account the latest results, the current consensus of the 13 analysts of Zai Lab in 2025 is $ 571.7 million. This would reflect a considerable increase in sales in the past 12 months. The loss per share is expected to be significantly reduced in the near future and 41% restrict to 1.40 US dollars. Before the latest income, the analysts forecast sales of $ 567.8 million and loss of USD 1.73 per share in 2025. While the sales estimates were largely unchanged, the mood seems to have improved, with the analysts upgrading their numbers and reducing losses per share, in particular a share.

The average price target was steadily at 52.54 US dollars and seemed to indicate that the business corresponds to the expectations. The consensus price goal is only an average of the individual analyst goals. The most optimistic Zai Lab -Analyst has a price target of $ 74.00 per share, while the most pessimistic estimates it at USD 29.00. This is a fairly broad spread of estimates, which indicates that analysts predict a wide range of possible results for the company.

If we look at the overall picture now, we can understand these forecasts to see how they compete against both the estimates of performance and the growth of the industry. We can conclude from the recent estimates that forecasts expect a continuation of Zai Lab's Historical trends, since the annualized sales growth of 43% of 43% in the past five years will match the annual growth of 43%. In contrast, our data indicate that other companies (with analyst coverage) are predicted in a similar industry to see that their income is growing by 20% per year. Although Zai Lab is expected to maintain its sales growth rate, it is definitely expected that it will be faster than the wider industry.

The most obvious conclusion is that the analysts have not changed their forecasts for a loss next year. Fortunately, there were no significant changes to sales forecasts, although the company will still grow faster than the wider industry. There was no real change in the consensus price, which indicates that the intrinsic value of the business with the latest estimates has not subjected any significant changes.

The story continues